Drugs / Nasal Spray Lyophilized Live Attenuated Influenza Vaccine
Nasal Spray Lyophilized Live Attenuated Influenza Vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04825340 | Apr 2021 → Mar 2022 | — | Changchun BCHT Biotechnology Co. | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nasal Spray Lyophilized Live Attenuated Influenza Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04825340 ↗ |
| Modality | Vaccine | “Nasal Spray Lyophilized Live Attenuated Influenza Vaccine” NCT04825340 ↗ |
| Route | Intranasal | “via intranasal injection of one dose of the study vaccine or placebo” NCT04825340 ↗ |